Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Expenditure

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Expenditure ₹25,141 Cr₹23,159 Cr₹21,137 Cr₹19,071 Cr₹19,441 Cr

What is the latest Total Expenditure of AUROBINDO PHARMA ?

The latest Total Expenditure ratio of AUROBINDO PHARMA is ₹25,141 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹25,141 Cr
Mar2024₹23,159 Cr
Mar2023₹21,137 Cr
Mar2022₹19,071 Cr
Mar2021₹19,441 Cr

How is Total Expenditure of AUROBINDO PHARMA Trending?

Years Total Expenditure % Change
Mar2025 ₹25,141 Cr
8.56
Mar2024 ₹23,159 Cr
9.57
Mar2023 ₹21,137 Cr
10.83
Mar2022 ₹19,071 Cr
-1.90
Mar2021 ₹19,441 Cr -

Compare Total Expenditure of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹74,304.6 Cr -0.5% 10.5% 18.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.5%

10.5%

18.6%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses